Senile Dementia China Prescription Drug Sales Data 2010Draco Healthcare Consulting LLCAugust 1, 2011 SKU: DCO6076974 |
| Countries covered: China 2011 China Prescription Drug Sales Database provides the following information: 1) 2010 national sales of individual therapeutic area 2) 2010 national sales from each of the top manufacturers in each therapeutic area 3) 2010 national sales and market shares for each of the top drugs in each therapeutic area 4) 2010 national sales of the top drugs by each of the competing manufacturers 5) Names, packages, prices and manufacturers of brand and generic drugs in each therapeutic area Please note: this is delivered as a Excel file. |
Additional Information
- 1. Top 20 Pharmaceutical Companies in China’s Anti-Allergic Drug Market (At least >0.84% of the Chinese anti-allergic drug market)
- Chongqing Huabang
- India Ranbaxy Labs
- Shenzhen Xinlitai
- Zhejiang Hangzhou Aoyi Baoling
- Beijing Shuanglu
- Chengdu Minyi
- Chongqing Kailin
- Guangdong Zhuhai Lianbang
- Hainan Puli
- Henan Sanmenxia Sainuo
- Hubei Yidu Dongyang
- Jiangsu Changzhou No 4 Pharma
- Jiangsu Lianhuan
- Nanjing Yihua
- Schering-Plough China
- Shandong Lunan
- Shenzhen Haibin
- Suzhou Weicai
- UCB
- Xian-Janssen
- 2. Top 20 Pharmaceutical Companies in China’s Anti-Asthma Drug Market(At least > 0.53% of the Chinese anti-asthma drug market)
- Boehringer Ingelheim
- Zhejiang Beisheng
- AstraZeneca
- GSK
- Guangdong Huanqiu
- Guangzhou Maite-Xinghua
- Guilin Nanyao
- Hangzhou MSD China
- Heilongjiang Fuhe Huaxing
- Draco
- Henan Kaifeng Kangnuo
- Hengyang Hengsheng
- Jiangsu China Medicine and Technology University
- Otsuka Pharmaceutical Co Ltd
- Qingzhou Yaowang
- Sankyo
- Shandong Hualu
- Shandong Ruiyang
- Shanghai Aidifa
- Sichuan Chengdu Huayu
- Zhejiang Changxing
- 3. Top 20 Pharmaceutical Companies in China’s Anti-BPH Drug Market(At least > 0.58% of the Chinese anti-BPH drug market)
- Changchun Yixin
- Madaus AG
- Polichem S.A.
- Xian Lijun
- Zhejiang Hailisheng
- Abbott Shanghai
- Beijing Saike
- Byk Gulden
- Hangzhou Sanofi-Synthelabo
- Hebei Taiyangshi
- Henan Tianfang
- Jiangsu Lianhuan
- Merck Sharp & Dohme MSD China
- Nanjing Meirui
- Pfizer Dalian
- Shandong Lunan
- Tianjin Tong Ren Tang
- Yamanouchi (Astellas)
- Zhejiang Kangenbei
- Zhejiang Xianju
- Draco
- 4. Top 20 Pharmaceutical Companies in China’s Anti-Depressant Drug Market (At least > 0.29% of the Chinese anti-depressant drug market)
- Changzhou Siyao
- Dr.Willmar Schwabe GmbH & Co
- Jiangsu Changzhou Huasheng
- Novartis
- Taiwan Lotus pharmaceutical Co
- Zhejiang Jianfeng
- Chengdu Daxinan
- Eli Lilly & Co
- H.Lundbeck A/S.
- Hunan Dongting
- N.V. Organon
- Pfizer Dalian
- Shanghai Zhongxi
- Sichuan Zhenzhu
- Solvay
- Tianjin Smith Kline & French laboratories Ltd
- Wuxi Huayu
- Wyeth-Whitehall (Suzhou)
- Zhejiang Huahai
- Zhejiang Jingxin
- 5. Top 20 Pharmaceutical Companies in China’s Anti-Dermatosis Drug Market (At least > 1.17% of the Chinese anti- dermatosis drug market)
- Chongqing Huabang
- Novartis
- Xian-Janssen
- Daiichi Seiyaku
- Tianjin Pharmaceutical
- Hong Kong Bright Future
- Schering-Plough China
- Tianjin SmithKline & French Laboratories Ltd.
- Shandong Qilu
- LEO Pharmaceutical
- Laboratories Galderma S.A
- Shanghai Likang
- Draco
- Shanghai Xinyi
- Luitpold-Werk, Chemisch-Pharma, Fabrik
- Bayer
- Jiangsu Jichuan
- Teijin Limited
- Sichuan Dikang
- Zhejiang Hangzhou Yishute
- GSK
- 6. Top 20 Pharmaceutical Companies in China’s Anti-Diabetics Drug Market (At least > 0.57% of the Chinese anti-diabetics drug market)
- Bayer
- Beijing Liling Hengtai
- Beijing Taiyang
- Eli Lilly
- GlaxoSmithKline
- Hangzhou Zhongmei Huadong Pharmaceutical Ltd.
- Jiangsu Hangshen
- Jiangsu Hengrui
- Jiangsu Wangbang BioChem Co
- Novartis
- Novo Nordisk
- Pfizer
- sanofi-aventis
- Servier (Tianjin)
- Shanghai BMS
- Taiji Group Chongqing Fuling Pharmaceutics
- Takeda
- Tonghua Dongbao
- Wanhui Shanghe
- Yangtze River
- Draco
- 7. Top 20 Pharmaceutical Companies in China’s Anti-Fungal Drug Market(At least > 0.51% of the total China’s anti-fungal drug market)
- Shanghai Sunve
- Bayer
- Chengdu Peite
- Chongqing Huabang
- Novartis
- Tianjin Lisheng
- Tianjin Smith Kline & French laboratories
- Xian-Janssen
- Yangtze River
- Zhuhai Yibang
- Abbott
- Alza Corporation
- Chengdu Huashen
- Hangzhou Mingsheng
- Jiangsu Tianhe Disainuo
- MSD
- Pfizer
- Shandong Qilu
- Shanghai Xinxianfeng
- Torrent Pharmaceuticals Ltd
- 8. Top 20 Pharmaceutical Companies in China’s Anti-Hypertension Drug Market (At least > 0.86% of the Chinese anti-hypertension drug market)
- Bayer
- Pfizer
- Novartis
- AstraZeneca
- MSD
- sanofi-aventis
- BMS
- Beijing Saike
- Jilin Tianfeng
- Servier
- Roche
- Merck
- Draco
- Yangtze River
- Boehringer-Ingelheim
- Altana Pharma AG
- Tanabe
- Suzhou Dong Rui Jiangsu Suzhou Dongrui
- Jiangsu Nanjing Xingang
- Beijing Huasu
- Shanghai Xiandai
- 9. Top 20 Pharmaceutical Companies in China’s Anti-Hyperlipidemics Drug Market (At least > 0.31% of the Chinese anti-hyperlipidemics drug market)
- Beijing Baihui
- Beijing Wansheng
- Ethypharm
- Henan Tianfang
- Jiangsu Huarui
- Laboratories Foumier S.A
- Pharmacia & Upjohn (Pfizer)
- Shandong Qilu
- Yangtze River
- Zhejiang Haizheng
- Zhejiang Jingxin
- Beida Weixin
- Beijing Honghui
- BMS
- Guangzhou Nanxin
- MSD
- Novartis
- Pfizer
- Sankyo
- Shandong Lunan
- Draco
- 10. Top 20 Pharmaceutical Companies in China’s Anti-Peptic Ulcer Drug Market (At least > 0.95% of the Chinese anti-peptic ulcer drug market)
- AstraZeneca
- Altana Pharma AG
- Bayer
- Changzhou Siyao
- Guangdong Lizhu
- Guangdong Tuobin
- Hainan Huanglong
- Hangzhou Zhongmei Huadong
- Jiangsu Haoshen
- Seiko Eiyo Yakuhin
- Shandong Luye
- Shandong Lunan
- Shanghai Xinyi
- Shenyang Dongyu
- Sichuan Dikang
- Weicai
- Xian-Janssen
- Yamanouchi
- Yangtze River
- Yangzhou Aosaikang
- 11. Top 20 Pharmaceutical Companies in China’s Sedative Hypnotic Drug Market (At least > 0.96% of the Chinese sedative hypnotic drug market)
- AstraZeneca
- Atlantic Laboratories Corp Ltd
- Changzhou Huasheng
- Chengdu Daxinan
- Eli Lilly & Co
- Guizhou Shengqi
- Guizhou Yikang
- H.Lundbeck A/S
- Hangzhou Sanofi-Synthelabo
- Hunan Dongting
- Kunming Zhiyao
- Roche
- Shandong Qilu
- Draco
- Shanghai Jiufu
- Suzhou No.1
- Wandashan
- Wusulijiang Pharma
- Xian-Janssen
- Xuzhou Enhua
- Zhejiang Yongning
- 12. Top 20 Pharmaceutical Companies in China’s Anti Senile Dementia Drug Market (At least > 0.96% of the Chinese anti senile dementia drug market)
- Harbin Sanlian
- Beijing Shuanghe
- Guangdong Shixin
- Guizhou Yibai
- Hainan Tongyong Sanyang
- Heilongjiang Feixia
- Heilongjiang Zhenbaodao
- Henan Lingrui
- Kunming Longjin
- Nanjing Xiansheng Dongyuan
- Shandong Qilu
- Shanghai Xinxianfeng
- Shanxi Pude
- Shanxi Wanrong
- Shijiazhuang Shenwei
- TRB Pharma S.A.
- Willmar Schwabe
- Yangtze River
- Yunnan Shengwugu Dengzhanhua (Herba Erigerontis)
- Hunan Jianlang
- Draco
- 13. Top 20 Pharmaceutical Companies in China’s Anti-Thrombotic Drug Market (At least > 0.85% of the Chinese anti-thrombotic drug market)
- Anhui Zhaoke
- Beijing Baiao
- Beijing Bituoxi
- Boehringer Ingelheim
- Changchun Haobang
- Changchun Jinyou
- Dalian Meiluo
- Dandong Yichuang
- GSK
- Guangdong Tianpu
- Hainan Bikai
- Hainan Tongyong Tongmeng
- Otsuka
- Pfizer
- sanofi-aventis
- Shenyang Jishi
- Shenzhen Xinlitai
- Tianjin Hongri
- Tianjin Shengwu
- Wuhan Yuanda
- 14. Top 20 Pharmaceutical Companies in China’s Blood Product Drug Market (At least > 1.21 % of the Chinese blood product drug market)
- Guangzhou Baiyunshan Qiaoguang
- Anhui Fengyuan
- Aventis Behring
- B. Braun Melsungen
- Baxter
- Beijing Shuanghe
- Chengdu Rongsheng
- Chongqing Xinan
- Fresenius Kabi
- Green Cross
- Harbin Sanlian
- Hualan Shengwu
- Jiangsu Huarui
- Draco
- Jinzhou Aohong
- Otsuka
- Shanghai RAAS
- Sichuan Kelun
- Sichuan Yuanda Shuyang
- Tianjin Tianan
- Wuxi Nutricia
- 15. Top 20 Pharmaceutical Companies in China’s Ophthalmological Market(At least > 0.88% of the Chinese Ophthalmological drug market)
- Santen Pharmaceutical Co
- Senju Pharmaceutical
- Shanghai Xinyi
- Alcon
- Allergan U.S.A.(US)
- Beijing Zizhu
- Ferring Pharmaceuticals
- Guangdong Zhuhai Lianbang
- Guangdong Zhuhai Yisheng
- Hubei Dongsheng
- Laboratories Leurquin Mediolanum SA
- Lizhu Group
- Novartis
- Otsuka Pharmaceutical Co
- Pharmacia Upjohn (Pfizer)
- Shandong Zhenda Furuida
- Shenyang Xinqi
- Shenzhen Huashengyuan
- Sichuan Shenghe
- Wuhan Wujing
- 16. Top 20 Pharmaceutical Companies in China’s Macrolide Antibiotics Drug Market (At least > 1.04% of the Chinese macrolide antibiotics drug market)
- Abbott
- Beijing Taiyang
- Dongbei Zhiyao
- Guangdong Lizhu
- Draco
- Hainan Sida
- Harbin Pharmaceutical Group
- Jiangsu Hengrui
- Jiangsu Jichuan
- Jiangsu Jinsili
- Pfizer
- Pliva
- POLFA
- Shandong Qilu
- Shenzhen Wanhe
- Shijiangzhuang Pharma
- Sichuan Kelun
- Xian Lijun
- Yangtze River
- Zhejiang Jianfeng
- Zhejiang Zhongyi
- 17. Top 20 Pharmaceutical Companies in China’s Anti-Cancer Drug Market(At least > 1.3 % of the Chinese anti-cancer drug market)
- Jiangsu Hansen Pharmaceutical Co., Ltd.(Hansen Pharma)
- Jiangsu Hengrui Medicine Co., Ltd
- Novartis
- Pfizer
- Roche
- sanofi-aventis
- Sichuan Diao Jiuhong Group Pharmaceutical Co
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Guizhou Baiqiang Pharmaceutical Co., Ltd.
- Hainan Zhonghe Pharmaceutical Co., Ltd
- JINLING PHARMACEUTICAL CO.,LTD
- LIVZON Pharmaceutical Group Inc.
- Nanjing Kanghai Pharmaceutical Co., Ltd
- Nanjing Sike Pharmaceutical Co. Ltd
- Qilu Pharmaceutical Co., Ltd
- SciClone Pharmaceuticals Italy S.R.l.
- Shenzhen Wanle Pharmaceutical Co,.Ltd
- Draco
- Zhejiang Hisun Pharmaceutical Co,.Ltd
- 18. Top 20 Pharmaceutical Companies in China’s Rheumatoid Arthritis Drug Market (At least > 1.08% of the Chinese rheumatoid arthritis drug market)
- Beijing Taide
- Boehringer Ingelheim
- Fujian Huitian
- German Fujisawa Deutschland GmbH
- Guilin Tianhe
- Harbin Yuheng
- Heilongjiang Dilong
- Heilongjiang Jiangshi
- Hong Kong Bright Future Pharmaceuticals Factory
- Johnson & Johnson
- Lingnan Pharma Hong Kong
- Novartis
- Nycomed Austria GmbH
- Pfizer
- Rotta Research Laboratorium S.P.A.
- Shanxi Zhongyuanwei
- Suzhou Changzhen Xinkai
- Tianjin SmithKline & French Laboratories Ltd
- Tibet Qizheng Zhangyao
- Zhejiang Haizheng
More China CNS/Neurology Reports
China Senile Dementia Prescription Drug Sales Data 2006-2010 by
Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...
China Depression Prescription Drug Sales Data 2006-2010 by
Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...
CNS Market Access in China - Investment in mental health services offers growth opportunities for psychiatry players by
Datamonitor
Introduction China’s expanding and aging population makes the country an attractive market for manufacturers of CNS products. Key CNS drug launches to have taken place in ...
Research Report on Chinese Anti Senile Dementia Drug Market, 2010-2011 by
China Research and Intelligence Co., Ltd.
According to statistics, the population aged 60 and above in China reached 167.14 million in 2009, accounting for 12.5% of the total population. It rose ...
Chinese Markets for Sleep Disorder Treatment Drugs by
Asia Market Information & Development Company
China's demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Juice – China – a snapshot (2010) by
Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...
See all reports like this >>
Related Markets
CNS/Neurology Reports
- Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
- Tension -Type Headache Global Clinical Trials Review, H1, 2012
- Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
- Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
- Brain Ischemia Global Clinical Trials Review, H1, 2012

